BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24668056)

  • 1. Micronucleus frequency in human peripheral blood lymphocytes as a biomarker for the early detection of colorectal cancer risk.
    Maffei F; Zolezzi Moraga JM; Angelini S; Zenesini C; Musti M; Festi D; Cantelli-Forti G; Hrelia P
    Mutagenesis; 2014 May; 29(3):221-5. PubMed ID: 24668056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk.
    Maffei F; Angeloni C; Malaguti M; Moraga JM; Pasqui F; Poli C; Colecchia A; Festi D; Hrelia P; Hrelia S
    Mutat Res; 2011 Sep; 714(1-2):88-92. PubMed ID: 21777595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of in vivo micronucleus formation in lymphocytes from the patients and its relation to malignant degrees of colorectal cancer].
    Ma GJ; Zhou JN; Chen SQ; Liu R; Xue KX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):365-7. PubMed ID: 15300635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening colonoscopy in first-degree relatives of patients with colorectal cancer.
    Barzin G; Ostovaneh MR; Tayebi S; Vahedi H; Ansari R
    Arch Iran Med; 2014 Feb; 17(2):115-7. PubMed ID: 24527972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps.
    Cassinotti E; Melson J; Liggett T; Melnikov A; Yi Q; Replogle C; Mobarhan S; Boni L; Segato S; Levenson V
    Int J Cancer; 2012 Sep; 131(5):1153-7. PubMed ID: 22020530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of DNA methylation in bowel lavage fluid for detection of colorectal cancer.
    Harada T; Yamamoto E; Yamano HO; Nojima M; Maruyama R; Kumegawa K; Ashida M; Yoshikawa K; Kimura T; Harada E; Takagi R; Tanaka Y; Aoki H; Nishizono M; Nakaoka M; Tsuyada A; Niinuma T; Kai M; Shimoda K; Shinomura Y; Sugai T; Imai K; Suzuki H
    Cancer Prev Res (Phila); 2014 Oct; 7(10):1002-10. PubMed ID: 25139296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
    Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
    Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micronucleus analysis in patients with colorectal adenocarcinoma and colorectal polyps.
    Karaman A; Binici DN; Kabalar ME; Calikuşu Z
    World J Gastroenterol; 2008 Nov; 14(44):6835-9. PubMed ID: 19058310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could the colonic capsule PillCam Colon be clinically useful for selecting patients who deserve a complete colonoscopy?: results of clinical comparison with colonoscopy in the perspective of colorectal cancer screening.
    Gay G; Delvaux M; Frederic M; Fassler I
    Am J Gastroenterol; 2010 May; 105(5):1076-86. PubMed ID: 19888198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colon capsule endoscopy as possible filter test for colonoscopy selection in a screening population with positive fecal immunology.
    Holleran G; Leen R; O'Morain C; McNamara D
    Endoscopy; 2014 Jun; 46(6):473-8. PubMed ID: 24824091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonoscopy in symptomatic patients with positive family history of colorectal cancer.
    Charalambopoulos A; Syrigos KN; Ho JL; Murday VA; Leicester RJ
    Anticancer Res; 2000; 20(3B):1991-4. PubMed ID: 10928139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
    Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
    Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy.
    Jobin G; Rodriguez-Suarez R; Betito K
    Gastroenterology; 2017 Oct; 153(4):980-987. PubMed ID: 28625834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans.
    Bonassi S; Znaor A; Ceppi M; Lando C; Chang WP; Holland N; Kirsch-Volders M; Zeiger E; Ban S; Barale R; Bigatti MP; Bolognesi C; Cebulska-Wasilewska A; Fabianova E; Fucic A; Hagmar L; Joksic G; Martelli A; Migliore L; Mirkova E; Scarfi MR; Zijno A; Norppa H; Fenech M
    Carcinogenesis; 2007 Mar; 28(3):625-31. PubMed ID: 16973674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of serum markers for the early detection of colorectal cancer.
    Wild N; Andres H; Rollinger W; Krause F; Dilba P; Tacke M; Karl J
    Clin Cancer Res; 2010 Dec; 16(24):6111-21. PubMed ID: 20798228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STUDY OF LIPID BIOMARKERS OF PATIENTS WITH POLYPS AND COLORECTAL CÂNCER.
    Serafim PVP; Figueiredo AG; Felipe AV; Turco EGL; Silva IDCGD; Forones NM
    Arq Gastroenterol; 2019; 56(4):399-404. PubMed ID: 31800736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro sensitivities to UVA of lymphocytes from patients with colon and melanoma cancers and precancerous states in the micronucleus and the Comet assays.
    Najafzadeh M; Baumgartner A; Gopalan R; Davies JB; Wright A; Reynolds PD; Anderson D
    Mutagenesis; 2012 May; 27(3):351-7. PubMed ID: 22155984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of a colonoscopic screening programme in first-degree relatives of patients with colorectal cancer.
    Puente Gutiérrez JJ; Marín Moreno MA; Domínguez Jiménez JL; Bernal Blanco E; Díaz Iglesias JM
    Colorectal Dis; 2011 Jun; 13(6):e145-53. PubMed ID: 21564467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.